Prediction and prognostic significance of BCAR3 expression in patients with multiple myelomaWeilong Zhang, Hongmei Jing, Yuansheng Lin et al.|Journal of Translational Medicine|2018Cited by 22
Multiple primary malignant neoplasms: A case report and literature reviewLinwei Zhang, Jing Wang, Lingxin Feng et al.|Oncology Letters|2019Cited by 18
A quantitative model of transcriptional differentiation driving host-pathogen interactionsSheng Zhu, Renhai Wu, Zhiqiang Wang et al.|Briefings in Bioinformatics|2012Cited by 8
Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non‐small cell lung cancer with sensitive EGFR mutationsYun Zhang, Lingxin Feng, Jing Wang et al.|Clinical and Translational Science|2020Cited by 6
MPN-343: The BET Inhibitor Pelabresib Decreases Inflammatory Cytokines, Improves Bone Marrow Fibrosis and Function, and Demonstrates Clinical Response Irrespective of Mutation Status in Myelofibrosis Patients in the Phase 2 MANIFEST TrialOksana Zavidij, Patrick Trojer, Patricia J. Keller et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 4